Google
WHWK — WHITEHAWK THERAPEUTICS, INC. (Healthcare >> Biotechnology)
WHWK FAQ
What is WHWK's ROE?
WHITEHAWK THERAPEUTICS, INC. reports a Return on Equity (ROE) of -99.68%.
What is WHWK's dividend yield?
WHITEHAWK THERAPEUTICS, INC. offers a dividend yield of 0.00%.
What is WHWK's Deepscope Quality Score?
Deepscope rates WHWK's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy WHWK?
Deepscope's AI Timing Score for WHWK is 70 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does WHWK belong to?
WHITEHAWK THERAPEUTICS, INC. is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 4.02
Price
-0.13
(-3.13%)
Day Change
|
|
|---|
WHWK, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 80 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 4.02 |
| PBV / Sector |
1.77 / 4.75
|
| Earning Per Share | -2.27 |
| PE / Sector |
N/A / 17.65
|
| PEG or PE/Growth / Sector |
N/A / 0.52
|
| Average 1M Daily Value |
2.50 M
GREAT
|
| Average 1W Daily Value |
0.90 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
43% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-09 09:40:14 |
| Symbol | WHWK |
| Name | WHITEHAWK THERAPEUTICS, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 49.45 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 205.23 / 9,000.42 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 2 Headquarters Plaza, Morristown, NJ, United States, 07960
Phone: 551-321-2234
Website: https://ir.whitehawktx.com
Sector: Healthcare >> Biotechnology
Description: Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
